Mabcampath and oliguria Patient Reports February 11, 2012

Mabcampath Side Effects Report #6073520-4
Mabcampath side effect was reported by a Physician from FRANCE on Feb 04, 2009. Female patient, 70 years of age, weighting 121.3 lb, was diagnosed with t-cell prolymphocytic leukaemia, prophylaxis and was treated with Mabcampath. After drug was administered, patient experienced the following side effects: blood blister, capillary leak syndrome, gingival bleeding, haematoma, injection site haemorrhage, oliguria, renal failure, respiratory failure. Mabcampath dosage: TOTAL DAILY DOSE: 3 MG. During the same period patient was treated with FLUDARA, FASTURTEC, ZYLORIC. Patient was hospitalized. Patient recovered.

Mabcampath Side Effects Report #6081550-1
Mabcampath side effect was reported by a Physician from FRANCE on Feb 04, 2009. Female patient, 70 years of age, weighting 121.3 lb, was diagnosed with t-cell prolymphocytic leukaemia, prophylaxis and was treated with Mabcampath. After drug was administered, patient experienced the following side effects: blood blister, capillary leak syndrome, gingival bleeding, haematoma, injection site haemorrhage, oliguria, renal failure, respiratory failure. Mabcampath dosage: TOTAL DAILY DOSE: 3 MG. During the same period patient was treated with FLUDARA, FASTURTEC, ZYLORIC. Patient was hospitalized. Patient recovered.

Mabcampath Side Effects Report #6088367-2
Mabcampath side effect was reported by a Physician from FRANCE on Feb 13, 2009. Female patient, 70 years of age, weighting 121.3 lb, was diagnosed with t-cell prolymphocytic leukaemia, prophylaxis and was treated with Mabcampath. After drug was administered, patient experienced the following side effects: blood blister, capillary leak syndrome, disseminated intravascular coagulation, gingival bleeding, haematoma, injection site haemorrhage, oliguria, renal failure. Mabcampath dosage: TOTAL DAILY DOSE: 3 MG. During the same period patient was treated with FLUDARA, FASTURTEC, ZYLORIC. Patient was hospitalized. Patient recovered.